- Home
- Digital Pcr Dpcr Market

Digital PCR-dPCR Market Size, Share & Segmentation by Technology Type (Droplet Digital PCR, Chip Based Digital PCR, Beaming Digital PCR), by Product (Digital PCR Systems, Consumables and Reagents, Software And Services), by Application (Clinical Diagnostics, Forensic And Others), by End Use (Pharmaceuticals And Biotechnology Industries, Clinical Diagnostic Laboratories), and by Region | Global Market Forecast
- Published Date: April, 2023 | Report ID: CLS-1926 | No of pages: 235 | Format:
Global Digital Polymerase Chain Reaction (DPCR) market is estimated to be worth USD 394.1 Million in 2022 and is projected to grow at a CAGR of 19.83% between 2021 to 2032. The study has considered the base year as 2022, which estimates the market size of market and the forecast period is 2021 to 2032. The report analyzes and forecasts the market size, in terms of value (USD Million), for the market. The report segments the market and forecasts its size, by product, by technology, by application, by end user and region/country.
The digital PCR-dPCR market size is expected to be valued at USD 2423.6 by 2032. The digital PCR market is segmented into technology, product type, application, and end-use. Based on the technology, digital PCR market is segmented into droplet digital PCR, chip digital PCR, and beaming digital PCR. Based on the product type, digital PCR-dPCR market is segmented into digital PCR systems, consumables and regents, and software and services. Based on the application, digital PCR market is segmented into clinical diagnostics, forensic and others, and research. Based on the end use, dPCR market is segmented into pharmaceuticals and biotechnology industries and clinical diagnostic laboratories.
Top-down and bottom-up approaches are used to validate the global Digital Polymerase Chain Reaction (DPCR) market size and to estimate the market size for company, regional division, type, end-user and application. In the complete market entree Digital Polymerase Chain Reaction (DPCR), both top-down and bottom-up approaches along with several data triangulation methods have been extensively utilized to perform market estimation and market forecast for the overall market division and subdivision listed in this report. Extensive qualitative and further quantitative analysis has also been done from all the numbers arrived at in the complete market Digital Polymerase Chain Reaction (DPCR) process to list key information throughout the report.
Drivers : Growing Advancement and Rising Prevalence Of Diseases
Advancement in digital PCR techniques holds great promise in detection of rare cancer biomarkers. For instance, researchers are expected to use digital droplet PCR (ddPCR) along with molecular biology techniques to discover new cancer biomarkers. Thus, such a growing advancement and rising prevalence of diseases provide huge potential for adoption of PCR techniques
Many Industries are working closely with Digital Polymerase Chain Reaction (DPCR)s, regulations can impose some serious burden. With the advent of financial regulations to meet SEC reporting expectations. Financial expertise finds themselves tied up in red tape rather than performing required tasks. These are majorly consequential in large organizations in which varying departments handle reporting in disparate ways.
Competitive Scenario
Thermo Fisher Scientific, Bio-Rad Laboratories Inc., Hoffmann-La Roche, Ltd., Abbott Laboratories, Agilent Technologies, Analytik Jena AG, Becton Dikinson and Company, bioMrieux SA, Danaher Corporation, Eppendorf, Fluidigm Corporation, Merck KGaA, QIAGEN N.V., Takara Bio, Meridian Bioscience, Promega Corporation, Enzo Life Sciences, Inc., Bioneer, ELITech Group, Quidel Corporation, and Others
Bargaining Power of Suppliers (Low to Moderate)
The bargaining power of supplier is moderate in this market as there are few ad exchanges in the market hence the bargaining power is low. Suppliers can also influence industry decision making due to the rising demand among end consumers.
The reason for a low bargaining power is the limited supplier in the market. Also, supplier of this market facilitates forward integration, and impose an additional cost to the production process.
Bargaining Power of Buyers (Moderate)
Bargaining power of buyers, which in this case means end customers (brand who spend on advertising).
They have a moderate control as the rates that advertisers pay for Digital Polymerase Chain Reaction (DPCR) continues to drop, an indication that the buyers have the leverage in this marketplace.
Threat of New Entrants (Moderate to low)
The threat of new entrants in the market is observed low due to major players who has already marked their presence in this market. Moreover, emerging companies are trying to make their presence by attracting customers through new product launch, strategic collaboration and acquisitions in this market.
Emerging economies and developed countries are expected to offer significant growth opportunities for the market players operating in the market.
Threat of Substitutes (High)
The threat of substitute is high as there are involvement of limited user interface affecting the navigation performance and coming up of new technologies acting as disruptors.
Presence of these substitute in the market may limit the market growth for this market.
Intensity of Rivalry
The intensity of rivalry is higher in the market as few major giants or players who are involved in new launch and acquisition of products, which is resulting in high competition among players.
These acquisitions by the players in the market is driving the market growth.
TABLE OF CONTENT
Table of Contents:
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID 19 Impact Analysis
5. Value Chain Analysis
6. Porter's 5 forces model
7. PEST Analysis
8.Digital PCR-dPCR Market Segmentation, by Technology type
8.1 Droplet Digital PCR
8.2 Chip Based Digital PCR
8.3 Beaming Digital PCR
9.Digital PCR-dPCR Market Segmentation, by Product type
9.1 DIgital PCR Systems
9.2 Consumables And Reagents
9.3 Software And Services
10. Digital PCR-dPCR Market Segmentation, By application
10.1 Clinical Diagnostics
10.2 Forensic And Others
10.3 Research
11.Digital PCR-dPCR Market Segmentation, By End Use
11.1 Pharmaceuticals And Biotechnology Industries
11.2 Clinical Diagnostic Laboratories
11.3 Universities And Other Organizations
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 USA
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 France
12.3.4 Italy
12.3.5 Spain
12.3.6 The Netherlands
12.3.7 Rest of Europe
12.4 Asia-Pacific
12.4.1 Japan
12.4.2 South Korea
12.4.3 China
12.4.4 India
12.4.5 Australia
12.4.6 Rest of Asia-Pacific
12.5 The Middle East & Africa
12.5.1 Israel
12.5.2 UAE
12.5.3 South Africa
12.5.4 Rest
12.6 Latin America
12.6.1 Brazil
12.6.2 Argentina
12.6.3 Rest of Latin America
13.Company Profiles
13.1Thermo Fisher Scientific
13.1.1 Financial
13.1.2 Products/ Services Offered
13.1.3 SWOT Analysis
13.1.4 The Cognate Life science view
13.2 Bio-Rad Laboratories Inc.,
13.3 Hoffmann-La Roche, Ltd. (Switzerland)
13.4 Abbott Laboratories
13.5 Agilent Technologies
13.6 Analytik Jena AG (Switzerland)
13.7 Becton Dikinson and Company
13.8 bioMérieux SA (France)
13.9 Danaher Corporation
13.10 Eppendorf (Germany)
13.11 Fluidigm Corporation
13.12 Merck KGaA (Germany)
13.13 QIAGEN N.V. (Netherlands)
13.14 Takara Bio (Japan)
13.15 Meridian Bioscience
13.16 Promega Corporation
13.17 Enzo Life Sciences, Inc.
13.18 Bioneer (South Korea)
13.19 ELITech Group (France)
13.20 Quidel Corporation.
14.Competitive Landscape
14.1 Competitive Benchmarking
14.2 Market Share analysis
14.3 Recent Developments
15.Conclusion
Segmentation
Digital PCR-dPCR Market Segmentation
By Technology
Droplet Digital PCR
Chip Based Digital PCR
Beaming Digital PCR
By Product Type
Igital PCR Systems
Consumables And Reagents
Software And Services
By Application
Clinical Diagnostics
Forensic And Others
Research
By End-Use
Pharmaceuticals And Biotechnology Industries
Methodology
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
© 2025 Cognate Lifesciences. All Rights Reserved.